Suresh Subramanian
-
EY Parthenon, BioAsia’s latest report reveals GenAI’s impact on drug development
According to the report, Indian pharma companies are incorporating AI algorithms into their R&D operations, clinical trials and streamlining processes …
Read More » -
EY Parthenon – OPPI identifies three key focus areas crucial for Indian pharma and healthcare sector, sets 2047 milestone
The report for a resilient innovation ecosystem to foster collaborative engagement between stakeholders EY Parthenon (EY-P), the leading strategy consulting…
Read More » -
E&Y unveils report on next-gen digital, data-driven health and sustainable practices
The report highlights critical aspects of digital technology, data, and sustainability in shaping the next generation of humanised healthcare Ernst…
Read More »